Chaga Mushroom
traditional immune support and antioxidant properties
mushroomAntioxidant-dense mushroom traditionally used for immunity and gut health.
Quick answer
What it is: Chaga mushroom (Inonotus obliquus) is a fungus that grows primarily on birch trees in cold climates.
May support:Mold Illness / CIRS
Evidence Summary
The current evidence grade for chaga mushroom is low due to a significant lack of human clinical trials. Most available research consists of in vitro studies using cell lines and in vivo studies conducted in animal models. While these studies suggest potential biological activities, they do not directly translate to efficacy or safety in humans. Therefore, claims regarding health benefits are largely theoretical or based on traditional use rather than robust scientific validation in humans.
Last reviewed · Jun 2026
Have you tried Chaga Mushroom?
Vote in 5 seconds. Add details if you want.
Your experience for Mold Illness / CIRS:
Commonly Combined With
Other remedies frequently used alongside this one — from curated relationships, community reports, and shared protocols.
Community signal breakdown
Where this remedy is being discussed across the web and community.
People Like Me insights
As more members share outcomes, RemedyAtlas will show which remedies helped people with similar conditions, symptoms, goals, and lab patterns.
Community Discussions
What people say about Chaga Mushroom
Latest News
Latest news on Chaga Mushroom
Health Videos
Health videos on Chaga Mushroom
Why It Works
How it works in more detail
How to use
Always consult a qualified clinician.Editorial guidance
- Anticoagulants
- Antiplatelet drugs
- Antidiabetic drugs
- Immunosuppressants
- Taking anticoagulant medications
- Kidney disease
- Pregnant or breastfeeding
- Autoimmune conditions (use with caution)
Community tips
No community tips yet — be the first to share what worked for you.
Suggested dosage
General guidance — discuss specifics with a clinician.
Active medicinal compounds
Traditional use
Safety
Safety warnings
Avoid if
- Taking anticoagulant medications
- Kidney disease
- Pregnant or breastfeeding
- Autoimmune conditions (use with caution)
Medication interactions
- Anticoagulants
- Antiplatelet drugs
- Antidiabetic drugs
- Immunosuppressants
Reported side effects
- Kidney stones (with excessive consumption due to oxalates)
- Hypoglycemia (potential with high doses)
General guidance — discuss specifics with a clinician.
Evidence ecosystem
Scientific literature, clinical guidance, government sources, ongoing research, traditional use, and lived experience — grouped by source type and quality.
Overall grade
The current evidence grade for chaga mushroom is low due to a significant lack of human clinical trials. Most available research consists of in vitro studies using cell lines and in vivo studies conducted in animal models. While these studies suggest potential biological activities, they do not directly translate to efficacy or safety in humans. Therefore, claims regarding health benefits are largely theoretical or based on traditional use rather than robust scientific validation in humans.
Clinical Guidelines(1)
Recommendations from medical societies (NICE, AHA, ADA, ACG, Endocrine Society…).
[The Latin-American Consensus on Chronic Constipation].
Schmulson Wasserman M, Francisconi C, Olden K, Aguilar Paíz L, Bustos-Fernández L, Cohen H · Gastroenterologia y hepatologia · 2008
The Latin-American Consensus on Chronic Constipation aimed to establish guidelines to improve the identification, diagnosis and treatment of this disorder in the region. Two coordinators and an honorary coordinator established the process and the topics to be discussed, based on a systematic review of the literature published in the previous 10 years, since 1995. Seventeen members participated with the support of their local gastroenterology societies. The members reviewed the different subjects based on the levels of evidence and grades of recommendation; the topics were then discussed in a plenary session. A written report was drafted and the coordinators prepared the final declarations to be submitted to a vote by all the members in October 2006. The consensus concluded that chronic constipation has an estimated prevalence of 5-21% in the region, with a female-to-male ratio of 3:1. Among individuals with constipation, 75% use some type of medication, with more than 50% using home re
Clinical GuidelinePubMed (Practice Guideline)Very High Quality
Limitations: A primary limitation is the absence of well-designed, placebo-controlled human clinical trials to confirm efficacy, determine optimal dosages, and assess long-term safety. Most studies are preclinical, which may not accurately reflect human physiological responses. Furthermore, variability in chaga sourcing, extraction methods, and standardization of active compounds across different preparations makes it challenging to compare study results and ensure consistent product quality.
This page is educational. Statements use phrases like "may support" and "has been studied for"because no remedy here is approved to cure, treat, or reverse any condition. Discussion happens on the ailment pages — community statistics here are derived from those reports. Always consult a qualified clinician.
Tried Chaga Mushroom?
Help others see what actually works.
Tried Chaga Mushroom?
Real-world results help others choose what's worth trying.